- Craig Rhodes appointed as Qureight Head of Partnerships
- VITROCELL system aims to improve drug and particle safety testing
- FDA approves Moderna’s updated COVID-19 vaccines targeting new variant
- Lilly secures conditional MHRA approval for new blood cancer treatment
- Rare and severe epilepsies – current treatments and advance therapeutics
- Rotzinger launches modular filling and capping platform for over-the-counter products
- Er-Kim to distribute CNX Therapeutics’ oncology drugs across Europe and Turkey
- The Pharma Files: With Professor Hatim Abdulhussein from Health Innovation Kent Surrey Sussex
- How pharma marketing needs to adapt as community pharmacies take centre stage
- European Commission approves HIV prevention injection
- EMA grants orphan drug designation for Roca’s treatment of radiation maculopathy
- The UK’s Life Sciences Sector Plan: a fresh launchpad or a continued labyrinth for the uptake of innovative medicines?
- Terumo to acquire Oxford spin-out OrganOx in $1.5b deal
- Neogap Therapeutics appoints Jonas Mattson to its board of directors
- FDA approves Wegovy for treatment of MASH in adults with liver fibrosis